CLGN Stock Summary and Trading Ideas (Collplant Biotechnologies Ltd. - | NASDAQ:CLGN)

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Collplant Biotechnologies Ltd. - trades on the NASDAQ stock market under the symbol CLGN.

As of September 30, 2026, CLGN stock price declined to $3.78 with 10,415 million shares trading.

CLGN has a beta of -0.52, meaning it tends to be less sensitive to market movements. CLGN has a correlation of 0.00 to the broad based SPY ETF.

CLGN has a market cap of $7.15 million. This is considered a Sub-Micro Cap stock.

Last quarter Collplant Biotechnologies Ltd. - reported $73,000 in Revenue and -$21.00 earnings per share. This fell short of revenue expectation by $-1 million and exceeded earnings estimates by $3.00.

In the last 3 years, CLGN traded as high as $69.90 and as low as $2.64.

CLGN has underperformed the market in the last year with a return of -87.8%, while the SPY ETF gained +16.1%. In the last 3 month period, CLGN fell short of the market, returning +3.1%, while SPY returned +3.2%. However, in the most recent 2 weeks CLGN has outperformed the stock market by returning +11.2%, while SPY returned +0.9%.

CLGN support price is $3.38 and resistance is $4.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLGN shares will trade within this expected range on the day.